875798-79-1 Usage
Uses
Used in Pharmaceutical Research and Development:
3-(4-AMINO-PHENYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a building block for the synthesis of complex molecules in the pharmaceutical industry. Its unique structure and functional groups make it a versatile intermediate for the development of new drug candidates.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(4-AMINO-PHENYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a key intermediate for the construction of various biologically active compounds. Its tert-butyl ester group offers protection for the carboxylic acid moiety, allowing for selective reactions and subsequent deprotection to yield the desired products.
Used in Drug Discovery:
3-(4-AMINO-PHENYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a potential precursor for the development of new drug candidates in drug discovery. Its amino-phenyl group can be further modified or functionalized to target specific molecular pathways, leading to the discovery of novel therapeutic agents.
Used in Chemical Research:
In chemical research, 3-(4-AMINO-PHENYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a model compound to study the reactivity and properties of tertiary amine derivatives. Its unique structure allows researchers to explore various synthetic routes and reaction mechanisms, contributing to the advancement of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 875798-79-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,7,9 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 875798-79:
(8*8)+(7*7)+(6*5)+(5*7)+(4*9)+(3*8)+(2*7)+(1*9)=261
261 % 10 = 1
So 875798-79-1 is a valid CAS Registry Number.
InChI:InChI=1/C16H24N2O2/c1-16(2,3)20-15(19)18-10-4-5-13(11-18)12-6-8-14(17)9-7-12/h6-9,13H,4-5,10-11,17H2,1-3H3
875798-79-1Relevant articles and documents
PROCESSES FOR THE PREPARATION OF NIRAPARIB AND INTERMEDIATES THEREOF
-
Paragraph 00208, (2019/03/05)
The present invention relates to novel procedures and novel intermediates useful in the synthesis of Niraparib or any salt thereof.
Imidazole derivatives, its pharmaceutical composition and use thereof
-
Paragraph 0544-0546, (2017/02/24)
Imidazolone compounds, pharmaceutically acceptable salts, solvates, polymorphs or prodrugs thereof are disclosed. Pharmaceutical compositions comprising above substances and uses for preventing and treating protein kinases related diseases, such as cancers, metabolic diseases, cardiovascular diseases and the like, are also disclosed.
FAK AND FLT3 INHIBITORS
-
, (2014/03/22)
The use of a compound of the formula (I): (Formula (I)) in the preparation of a medicament for treating Acute Myeloid Leukemia or a disease ameliorated by the inhibition of Flt3, or Flt3 and FAK.
FAK INHIBITORS
-
, (2012/09/10)
A compound of the formula (I): where R1 or R2 is a cycle amine group and R5 is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.
Development of a fit-for-purpose large-scale synthesis of an oral PARP inhibitor
Wallace, Debra J.,Baxter, Carl A.,Brands, Karel J. M.,Bremeyer, Nadine,Brewer, Sarah E.,Desmond, Richard,Emerson, Khateeta M.,Foley, Jennifer,Fernandez, Paul,Hu, Weifeng,Keen, Stephen P.,Mullens, Peter,Muzzio, Daniel,Sajonz, Peter,Tan, Lushi,Wilson, Robert D.,Zhou, George,Zhou, Guoyue
, p. 831 - 840 (2012/07/03)
Compound (1) a poly(ADP-ribose)polymerase (PARP) inhibitor has been made by a fit-for-purpose large-scale synthesis using either a classical resolution or chiral chromatographic separation. The development and relative merits of each route are discussed,
